Postprogression Prolongation of Survival in EGFR-Mutated Lung Cancer: Reconciling the ASPIRATION and IMPRESS Trials

David R Gandara, Mary Redman, Fred R. Hirsch

Research output: Contribution to journalComment/debate

2 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)300-301
Number of pages2
JournalJAMA oncology
Volume2
Issue number3
DOIs
StatePublished - Mar 1 2016

Fingerprint

Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
Lung Neoplasms
Mutation
Erlotinib Hydrochloride

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Postprogression Prolongation of Survival in EGFR-Mutated Lung Cancer : Reconciling the ASPIRATION and IMPRESS Trials. / Gandara, David R; Redman, Mary; Hirsch, Fred R.

In: JAMA oncology, Vol. 2, No. 3, 01.03.2016, p. 300-301.

Research output: Contribution to journalComment/debate

@article{26441f16532a45f5800e8a9c1c95aea4,
title = "Postprogression Prolongation of Survival in EGFR-Mutated Lung Cancer: Reconciling the ASPIRATION and IMPRESS Trials",
author = "Gandara, {David R} and Mary Redman and Hirsch, {Fred R.}",
year = "2016",
month = "3",
day = "1",
doi = "10.1001/jamaoncol.2015.4920",
language = "English (US)",
volume = "2",
pages = "300--301",
journal = "JAMA oncology",
issn = "2374-2437",
publisher = "American Medical Association",
number = "3",

}

TY - JOUR

T1 - Postprogression Prolongation of Survival in EGFR-Mutated Lung Cancer

T2 - Reconciling the ASPIRATION and IMPRESS Trials

AU - Gandara, David R

AU - Redman, Mary

AU - Hirsch, Fred R.

PY - 2016/3/1

Y1 - 2016/3/1

UR - http://www.scopus.com/inward/record.url?scp=84979567697&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84979567697&partnerID=8YFLogxK

U2 - 10.1001/jamaoncol.2015.4920

DO - 10.1001/jamaoncol.2015.4920

M3 - Comment/debate

C2 - 26720042

AN - SCOPUS:84979567697

VL - 2

SP - 300

EP - 301

JO - JAMA oncology

JF - JAMA oncology

SN - 2374-2437

IS - 3

ER -